Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Debt to Equity (2016 - 2025)

Palisade Bio (PALI) has disclosed Debt to Equity for 10 consecutive years, with $0.07 as the latest value for Q3 2025.

  • On a quarterly basis, Debt to Equity changed N/A to $0.07 in Q3 2025 year-over-year; TTM through Sep 2025 was $0.07, a N/A change, with the full-year FY2023 number at $0.01, changed N/A from a year prior.
  • Debt to Equity was $0.07 for Q3 2025 at Palisade Bio, up from $0.03 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.07 in Q3 2025 to a low of -$0.12 in Q2 2021.
  • A 3-year average of -$0.0 and a median of $0.02 in 2025 define the central range for Debt to Equity.